Home   Contact Us

Contact Us

If you have any questions concerning Circadin®, please click here.

For additional information, please contact us in Israel or Switzerland:

Neurim Pharmaceuticals LTD
27 Habarzel St
Tel-Aviv 69710
Israel
Tel: +972 3 768 4911
Fax: +972 3 649 4568
info@neurim.com

Neurim Pharmaceuticals AG
Turmstrasse 18
6312 Steinhausen
Switzerland
Tel: +41 41 740 46 70
Fax: +41 41 740 46 71
swissinfo@neurim.com

or fill in this form and we will contact you shortly:

  • Text size: A A A
  • Circadin

  • Recent news

    • Slenyto® (PedPRM) was approved by EMA for the treatment of insomnia in children and adolescents aged 2-18 with Autism Spectrum Disorder (ASD) and / or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient
    • NEURIM PHARMACEUTICALS RECEIVES POSITIVE CHMP OPINION FOR SLENYTO® (PEDIATRIC PROLONGED-RELEASE MELATONIN) FOR THE TREATMENT OF INSOMNIA IN CHILDREN WITH AUTISM SPECTRUM DISORDER (ASD)
    • Neurim Pharmaceuticals attends the INSAR Congress in Rotterdam, The Netherlands, May 9-11, 2018

  • Partners

    Partners